Ambarella, Inc. (AMBA) Cash Flow Statement
Ambarella, Inc. (AMBA) generated $27.3M of operating cash flow over the twelve months to 2026-07-31, spent $17.6M on capital expenditure and had free cash flow of $9.7M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
AMBAAmbarella, Inc.Follow AMBA — free
—
Price chart with a free account
- Market cap
- 2.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 23 Nov, in 30 days
| Line | FY2013 Jan 13 | FY2014 Jan 14 | FY2015 Jan 15 | FY2016 Jan 16 | FY2017 Jan 17 | FY2018 Jan 18 | FY2019 Jan 19 | FY2020 Jan 20 | FY2021 Jan 21 | FY2022 Jan 22 | FY2023 Jan 23 | FY2024 Jan 24 | FY2025 Jan 25 | FY2026 Jan 26 | TTM Jul 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 10.5 | 34.4 | 52.3 | 123.6 | 113.3 | 85.4 | 24.5 | 39.4 | 30.8 | 38.8 | 44.1 | 19.0 | 33.8 | 73.5 | 27.3 | |
| Capital expenditure | 1.5 | 1.7 | 1.4 | 2.1 | 2.7 | 3.7 | 2.9 | 1.8 | 2.0 | 9.7 | 15.1 | 12.0 | 10.4 | 15.5 | -17.6 | |
| Free cash flow | 9.0 | 32.6 | 50.9 | 121.5 | 110.6 | 81.7 | 21.5 | 37.6 | 28.8 | 29.1 | 29.0 | 7.0 | 23.5 | 58.0 | 9.7 | |
| Share repurchases | 0.0 | — | 0.0 | 0.0 | 20.2 | 54.8 | 99.9 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | — | |
| Stock-based compensation | 5.0 | 8.5 | 15.7 | 31.1 | 48.8 | 56.9 | 60.8 | 66.9 | 70.1 | 87.8 | 111.2 | 111.3 | 107.8 | 98.0 | — |
USD millions · SEC XBRL
Ambarella, Inc. — questions
- What is Ambarella, Inc.'s operating cash flow?
- $27.3M over the twelve months to 2026-07-31.
- How much does Ambarella, Inc. spend on capital expenditure?
- $17.6M over the twelve months to 2026-07-31.
- What is Ambarella, Inc.'s free cash flow?
- $9.7M over the twelve months to 2026-07-31: operating cash flow minus capital expenditure.
Every figure on this page comes from Ambarella, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.